A chitinase VpCHI-1 domain truncated mutant and its application in the degradation of crystalline chitin

By constructing a chitinase VpCHI-1 domain truncated mutant, the problem of the difficulty in degrading crystalline chitin was solved, and efficient hydrolysis of colloidal chitin to generate chitin oligosaccharides was achieved, which are suitable for marine resource utilization.

CN123107970APending Publication Date: 2026-11-17DALIAN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611624347.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-20
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing technologies are inefficient at degrading crystalline chitin. Ordinary single-domain chitinases have low degradation efficiency for poorly soluble crystalline substrates, and there is a lack of systematic research on the division of labor and cooperation mechanism of various domains of chitinases derived from Vibrio marineis.

Method used

A chitinase VpCHI-1 domain truncated mutant was provided, with amino acid sequences SEQ ID NO.2, SEQ ID NO.3, and SEQ ID NO.4. By constructing a recombinant plasmid and expressing it in Escherichia coli, the chitinase was able to efficiently degrade crystalline chitin.

Benefits of technology

The method achieves efficient hydrolysis of colloidal chitin to produce chitin oligosaccharides under mild reaction conditions. The product composition is controllable and suitable for marine resource utilization, with broad industrial application prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123107970A_ABST
    Figure CN123107970A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of enzyme engineering technology and discloses a chitinase VpCHI-1 domain truncated mutant and its application in the degradation of crystalline chitin. The chitinase VpCHI-1 domain truncated mutant has an amino acid sequence of one of SEQ ID NO.2, SEQ ID NO.3, and SEQ ID NO.4. This invention provides a chitinase mutant, enriching the types and sources of chitinases, and has broad application prospects in the degradation of crystalline chitin.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of enzyme engineering technology, specifically relating to a chitinase VpCHI-1 domain truncated mutant and its application in the degradation of crystalline chitin. Background Technology

[0002] Chitin, a structural polysaccharide formed by the polymerization of N-acetylglucosamine through β-1,4 glycosidic bonds, is widely found in shrimp and crab shells, diatoms, fungal cell walls, and insect exoskeletons. It is the second largest renewable polysaccharide resource in nature, second only to cellulose. Marine seafood processing generates a large amount of shrimp and crab shell waste, of which chitin accounts for 20-35% of the dry matter. The accumulation of large amounts of shell waste not only wastes resources but also causes nearshore environmental pollution. Therefore, the green resource utilization of shell resources has significant research value.

[0003] Chitin can be enzymatically hydrolyzed to produce chitosan oligosaccharides, N-acetylglucosamine, and other products. These substances possess various biological activities, including antioxidant, antibacterial, anti-inflammatory, immunomodulatory, and anti-tumor proliferation effects, and can be used as food additives, feed additives, and biopharmaceutical raw materials. Currently, the preparation of chitin oligosaccharides mainly relies on chemical acid-base hydrolysis, which involves harsh reaction conditions, uneven polymerization of products, and severe environmental pollution. Utilizing chitinases for biodegradation offers milder reaction conditions, high substrate specificity, and controllable hydrolysis to prepare active oligosaccharides, making it a current research hotspot in green preparation processes.

[0004] Chitinases are classified into endochondral and exochondral chitinases based on their glycosidic bond cleavage patterns. Naturally occurring crystalline chitin molecules are densely packed, and common single-domain chitinases exhibit low degradation efficiency for poorly soluble crystalline substrates. Modular GH18 family chitinases contain multiple auxiliary domains; the overall catalytic efficiency depends not only on the GH18 catalytic domain but also on the collaborative work of auxiliary domains such as PKD and ChtBD3 to achieve substrate recognition, anchoring, and binding. Currently, the division of labor and cooperation mechanisms among the domains of marine Vibrio-derived chitinases are unclear, and systematic studies on the degradation patterns of crystalline chitin by different truncated mutants are lacking. Summary of the Invention

[0005] To overcome the shortcomings of the prior art, the present invention provides a chitinase VpCHI-1 domain truncated mutant and its application in the degradation of crystalline chitin. The present invention provides a chitinase mutant, which enriches the types and sources of chitinases, and has broad application prospects in the degradation of crystalline chitin.

[0006] The above-mentioned objective of the present invention is achieved by the following technical solution: a chitinase VpCHI-1 domain truncated mutant, the amino acid sequence of which is one of SEQ ID NO.2, SEQ ID NO.3, and SEQ ID NO.4 (corresponding to PKD-GH18-PKD-PKD, PKD-GH18, and GH18, respectively).

[0007] The amino acid sequence of the wild-type chitinase before mutation of the above-mentioned chitinase VpCHI-1 domain truncated mutant is shown in SEQ ID NO.1.

[0008] On the other hand, the present invention provides a coding gene for a chitinase VpCHI-1 domain truncated mutant.

[0009] Specifically, the nucleotide sequences encoding the gene are shown in SEQ ID NO.5, SEQ ID NO.6 and SEQ ID NO.7 (corresponding to PKD-GH18-PKD-PKD, PKD-GH18 and GH18, respectively).

[0010] In another aspect, the present invention provides a vector comprising the above-mentioned coding gene.

[0011] Specifically, the vectors include, but are not limited to, plasmids, viruses, and bacteriophages.

[0012] Preferably, the vector is a pET28a(+) plasmid.

[0013] In another aspect, the present invention provides a host cell containing the above-described encoding gene or the above-described vector.

[0014] Specifically, the host cell includes, but is not limited to, microbial, plant, or animal cells, and the vector of the present invention can be introduced into the host cell by methods known to those skilled in the art, such as heat shock conversion.

[0015] More specifically, the host cell is Escherichia coli, preferably E. coli BL21(DE3).

[0016] In another aspect, the present invention provides the application of the above-mentioned encoding gene, vector or host cell in the preparation of chitinase mutants.

[0017] In another aspect, the present invention provides a method for preparing the above-mentioned chitinase truncated mutant, comprising the following steps: (1) The above nucleic acid molecules are linked to a plasmid vector to obtain a recombinant plasmid; (2) The recombinant plasmid is transformed into the cloning strain to obtain the recombinant cloning strain; (3) Extract the plasmid from the recombinant clone strain and transform it into the expression strain to obtain the recombinant expression strain; (4) The recombinant expression strain was induced and cultured, the cells were collected and broken to obtain chitinase.

[0018] Induction culture process: The recombinant engineered bacteria were inoculated into 10 mL of LB liquid medium containing 50 μg / mL kanamycin and activated by incubation at 37°C and 180 r / min for 12–16 h to obtain seed culture. 1 mL of seed culture was transferred to 100 mL of fresh medium and amplified under the same conditions for 5 h. IPTG was then added to achieve a final concentration of 0.15 mmol / L, and the culture was incubated overnight at 15°C and 100 r / min.

[0019] In another aspect, the present invention provides the application of the above-mentioned chitinase truncated mutant in the degradation of natural crystalline chitin to prepare chitin oligosaccharides.

[0020] In some embodiments, the products of enzymatic hydrolysis of colloidal chitin by the chitinase C-terminus truncated mutants (PKD-GH18-PKD-PKD, PKD-GH18, GH18, corresponding to SEQ ID NO.2, SEQ ID NO.3, and SEQ ID NO.4, respectively) provided by the present invention are mainly GlcNAc and (GlcNAc)2, with a small amount of intermediate product (GlcNAc)3 generated. All the truncated mutants are basophilic chitinases with an optimal pH of 8.0. At pH 7.0, they maintain 60% of their maximum enzyme activity; at pH 9.0, they retain over 90% of their relative activity; and at pH 11.0, the residual enzyme activity is approximately 70%. The optimal reaction temperature for these truncated mutants is 35℃. They exhibit good thermal stability in the 0-40℃ range. PKD-GH18-PKD-PKD retains over 80% of its enzyme activity after incubation at 0-40℃ for 3 hours. After treatment at 50℃ for 3 hours, PKD-GH18-PKD-PKD retains approximately 60% of its activity, PKD-GH18 retains 55%, and GH18 retains only 40%. High-temperature stability gradually decreases with the removal of the PKD auxiliary domain. At temperatures above 50℃ or below 0℃, the enzyme activity of all mutants drops sharply to approximately 15%.

[0021] The advantages of this invention compared to the prior art are: (1) The C-terminal truncated mutant of the present invention fully retains the catalytic properties of the full-length chitinase. The hydrolysis of colloidal chitin can be directed to generate GlcNAc and (GlcNAc)2. The reaction conditions are mild, pollution-free, and have strong substrate specificity. (2) The truncated protein has a smaller molecular weight, making it easier to achieve prokaryotic soluble expression and lower protein purification costs. At the same time, it retains excellent alkali resistance and is suitable for marine, alkaline aquaculture and other application scenarios. (3) The bioactivity of the chitin oligosaccharide products prepared by hydrolysis is better than that of ordinary chitosan oligosaccharide. The product composition is controllable and has broad industrial application prospects in the fields of agricultural disease resistance induction and food antioxidant. Attached Figure Description

[0022] The present invention will be further described below with reference to the accompanying drawings and specific embodiments. Figure 1 It is the domain of chitinase VpCHI-1 and its truncated form; Figure 2 It is the three-dimensional structure of chitinase VpCHI-1; Figure 3 These are electrophoresis images of PKD-GH18-PKD-PKD, PKD-GH18, and GH18 recombinant plasmids after double enzyme digestion; Figure 4 It is the amplification and expression of the target gene in PKD-GH18-PKD-PKD, PKD-GH18, and GH18 clone-positive strains. Figure 5 This is an electrophoresis image of the purified chitinase VpCHI-1 and its truncated form; Figure 6 Analysis of the optimal pH and pH stability of the truncated form of chitinase VpCHI-1; Figure 7 It is the optimal temperature and temperature stability of the truncated form of chitinase VpCHI-1; Figure 8 It is substrate-specific for VpCHI-1 and its truncated derivatives; Figure 9 This is an analysis of the enzymatic kinetics of the VpCHI-1 truncated form; Figure 10 These are the kinetic parameters of chitinase VpCHI-1 and its truncated form; Figure 11 These are scanning electron microscope images of crab shells after the degradation of VpCHI-1 and its truncated form. Detailed Implementation

[0023] The present invention is described in detail below through specific embodiments, but this does not limit the scope of protection of the present invention. Unless otherwise specified, the experimental methods used in the present invention are all conventional methods, and the experimental equipment, materials, reagents, etc. used can all be obtained commercially.

[0024] Example 1: Construction of the truncated form of chitinase VpCHI-1 Three different truncated variants of chitinase PKD-GH18-PKD-PKD, PKD-GH18, and GH18 with specific domain deletions were constructed. The designed truncated variant schemes were submitted to Kangwei Century Biotechnology Co., Ltd. to complete the synthesis of the target gene fragment.

[0025] The synthesized gene and pET28a(+) vector were treated with double enzyme digestion using XbaI and XhoI. The enzyme digestion efficiency was verified by agarose gel electrophoresis. The linearized vector and target fragment were purified using a gel recovery kit. The electrophoresis results are shown in Figure 3.

[0026] The target gene was ligated to the pET28a(+) vector using T4 ligase to construct the recombinant plasmid pET28a-target gene.

[0027] The recombinant plasmid was introduced into Escherichia coli BL21(DE3) competent cells using heat shock transformation technology. The cells were then plated and cultured on LB solid medium containing 50 μg / mL kanamycin. After overnight culture at 37°C, single colonies were picked for small-scale amplification.

[0028] The results were verified by plasmid extraction and XbaI / XhoI double digestion, as shown in Figure 4.

[0029] Strains that meet the expected size are purified by streak filtration and stored long-term in LB medium containing 25% glycerol at -80°C.

[0030] Finally, the validation strain was sent to Kangwei Century Biotechnology Co., Ltd., where Sanger sequencing was used to detect mutation sites and enzyme ligation regions in full coverage to ensure sequence correctness and provide a reliable engineered strain for subsequent protein expression and functional validation.

[0031] Example 2: Induction and purification of chitinase VpCHI-1 truncated variant The chromatography purification procedure is as follows: First, all reagents are filtered through a 0.22 μm filter membrane to prevent column blockage. Then, 2 mL of Ni-NTA resin is packed vertically into the column, and the column is washed with 20 mL of ultrapure water to remove Ni. 2 + Residual, 5 mL binding buffer equilibrate the column.

[0032] After cycling the bacterial cell lysis supernatant five times and collecting the permeate, non-specific adsorbed proteins were washed with 10 mL of binding buffer, and then weakly bound contaminating proteins were eluted with a low concentration of imidazole.

[0033] Next, fractional elution was performed using a gradient of imidazole solutions (20, 40, 80, 100, 150, 300 mM, 6 gradients, 4 mL each), and finally, the target protein was completely eluted with 10 mL of 300 mM high-concentration imidazole.

[0034] After purification, the chromatography column was reequilibrated with binding buffer, perfused with 4 mL of 0.1 M NiSO4 solution, and stored at 4 °C. Elution buffer from each stage was collected, and 50 μL was mixed with loading buffer for SDS-PAGE analysis. Protein purity and elution efficiency were assessed by electrophoresis bands, allowing for optimization of purification conditions.

[0035] The supernatant from the bacterial lysate after five cycles of loading was centrifuged and injected into the chromatography column system. The column was washed with 20 mL of binding buffer to remove non-specifically adsorbed components. The elution program was performed in two gradients: first... Impurities were eluted with 4 mL of a low concentration (80 mM) imidazole solution, followed by specific elution of the target enzyme VpCHI-1 with 10 mL of an optimized concentration (150 mM) imidazole buffer, with simultaneous collection of eluting components at each stage.

[0036] After elution, protein concentration and desalting were performed using an ultrafiltration device with a molecular weight cutoff of 10 kDa (centrifugation parameters: pre-cooling at 4℃, 3000 × g for 40 min). Purity was assessed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and protein quantification was performed using a modified biuret BCA reagent system. Recombinant proteins with apparent molecular weights of approximately 84.31 kDa, 64.78 kDa, and 50.69 kDa were obtained by nickel column affinity chromatography purification of three VpCHI-1 truncated variants (PKD-GH18-PKD-PKD, PKD-GH18, and GH18), as shown in Figure 5.

[0037] The results showed that lanes 1-2 contained the purified VpCHI-1 holoenzyme; the remaining truncated variants were effectively eluted at specific imidazole concentrations: PKD-GH18-PKD-PKD showed relatively pure bands in elution buffers of 100 mmol / L and 150 mmol / L imidazole (Figure 5.a), and PKD-GH18 was mainly obtained by elution under imidazole conditions of 150 mmol / L and 300 mmol / L. Figure 5 .b), while GH18 showed higher purity in the elution peaks at 100 mmol / L and 150 mmol / L imidazole ( .b). Figure 5(Figure 5.b) PKD-GH18-PKD-PKD and PKD-GH18 showed good purification results, with single bands consistent with the theoretical molecular weight, indicating successful and efficient purification. However, GH18 still showed a small number of impurities in the eluted sample (Figure 5.b), indicating relatively poor purification, possibly related to the structural characteristics or expression stability of this truncated form. These results demonstrate that different truncated forms have varying affinities for the nickel column, but all yielded recombinant proteins suitable for subsequent enzymatic characterization.

[0038] Example 3: Enzymatic properties and hydrolysis product analysis of the truncated form of chitinase VpCHI-1 In this study, the VpCHI-1 series of truncated derivatives were constructed. Using 2% (w / v) colloidal chitin as a substrate, the activity of each truncated derivative at different temperatures (pH 8.0) in a 20 mmol / L Tris-HCl buffer system was first determined to identify its optimal reaction temperature. The thermal stability was then assessed by measuring the residual activity after pre-incubation at different temperatures for 3 hours.

[0039] Meanwhile, the activity at different pH values ​​was measured at 35 °C to determine the optimal pH, and the pH stability was assessed by measuring the residual activity after incubating the enzyme solution in different pH buffers at 4 °C for 3 hours.

[0040] All activity data were normalized to 100% of the highest observed activity to calculate relative activity. Furthermore, under optimal conditions (35 °C, pH 8.0), the substrate hydrolysis process of representative truncated forms at 2, 4, 6, 8, and 24 hours of reaction was monitored using high-performance liquid chromatography (HPLC, Shimadzu LC-20 system, TSK gelAmide-80 column, mobile phase 70% acetonitrile, flow rate 1 mL / min, detection wavelength 195 nm). Data were visualized and statistically analyzed using Origin 2021 software to reveal the impact of different domain deletions on enzyme catalytic properties and stability. Figure 6 As shown in Figure 7.

[0041] The results showed that the truncated forms of chitinase VpCHI-1 (PKD-GH18-PKD-PKD, PKD-GH18, GH18), like their full-length counterparts, are alkalophilic enzymes with an optimal pH of 8.0. At pH 7.0, their activity is approximately 60% of their maximum level; under acidic conditions at pH 3.0, the activity drops to about 20%. Each truncated form exhibits outstanding stability in alkaline environments, maintaining over 90% of its relative activity at pH 9.0, and retaining approximately 70% of residual enzyme activity even after treatment at pH 11.0. Conversely, enzyme activity significantly decreases below pH 7.0, and is almost completely lost at pH 3.0-4.0, further confirming its adaptability to alkaline environments.

[0042] When the temperature exceeds 50 °C or falls below 0 °C, the enzyme activity of each truncated variant drops sharply to approximately 15%, demonstrating its sensitivity to temperature. Regarding temperature stability, PKD-GH18-PKD-PKD retains over 80% of its activity after 3 hours of treatment within the 0-40 °C range; PKD_GH18 and GH18 maintain similar stability within the 0-30 °C range. After 3 hours of treatment at 50 °C, PKD_GH18_PKD_PKD retains approximately 60% of its activity, while PKD_GH18 and GH18 retain approximately 55% and 40% of their activities, respectively. When the temperature rises to 55 °C, the residual enzyme activity of each truncated variant rapidly decreases to below 20%, indicating that these truncated variants possess some thermal stability but are highly sensitive to high temperatures, and that thermal stability gradually decreases with the reduction of accessory domains.

[0043] High-performance liquid chromatography (HPLC) analysis of the truncated enzyme revealed that the major products of its hydrolysis of colloidal chitin were completely identical to those of the full-length enzyme, namely (GlcNAc)2, (GlcNAc)3, and GlcNAc. Throughout the reaction, (GlcNAc)3 consistently exhibited low-accumulation intermediate characteristics, while (GlcNAc)2 and GlcNAc were the major final products. This high consistency in product characteristics with the full-length enzyme demonstrates that truncation did not alter its core catalytic function or multi-step hydrolysis mechanism.

[0044] The three truncated forms of VpCHI-1 (PKD-GH18-PKD-PKD, PKD-GH18, and GH18) show virtually no change in their core enzymatic properties (optimal pH 8.0, optimal temperature 35 °C, alkali-loving and alkali-tolerant, and low-temperature adaptability) and hydrolysis product profiles compared to the full-length enzyme. This result indicates that the catalytic domain (GH18) plays a decisive role in the enzyme's catalytic properties and product formation, while the removal of the PKD domain does not affect its basic catalytic mechanism and stability. The truncated forms also possess multiple activities including endonuclease, exonuclease, and glycosidase, enabling efficient hydrolysis of colloidal chitin to (GlcNAc)2 and GlcNAc.

[0045] Example 4: Substrate specificity analysis of chitinase VpCHI-1 truncated variant The substrate specificity of purified VpCHI-1 and its truncated mutants was determined by detecting their hydrolytic activity against chitin substrates of different polymeric forms.

[0046] The specific experiments used α-chitin, β-chitin, and colloidal chitin as representative substrates. The reaction system was as follows: the above substrates were added to 20 mmol / L Tris-HCl buffer (pH 8.0) to a final concentration of 2% (w / v), followed by the addition of purified enzyme solution to a final concentration of 50 μg / mL. The reaction system was incubated in a 35°C water bath for 30 minutes, and then immediately boiled to terminate the reaction.

[0047] The catalytic activity of each enzyme on different substrates was quantified by detecting the amount of reducing sugar generated in the reaction system (using the DNS method).

[0048] Each substrate was tested in triplicate, with a system without enzyme solution serving as a blank control. The data obtained will be used to compare the catalytic preference of VpCHI-1 and its truncated mutants for chitin with different crystal structures, as shown in Figure 8.

[0049] This study compared the catalytic properties of chitinase VpCHI-1 and its truncated variants on different forms of chitin substrates. The results showed that all enzymes exhibited the highest activity on colloidal chitin. The full-length VpCHI-1 showed the broadest substrate spectrum, with relative activities of 90% and 35% for β-chitin and α-chitin, respectively. Notably, the truncated variant containing only the GH18 catalytic domain almost completely lost its hydrolytic ability on native α-chitin and β-chitin, confirming that while the catalytic domain alone retains catalytic function, it cannot effectively bind highly crystalline native chitin. With the retention of the PKD domain (PKD-GH18-PKD-PKD and PKD-GH18 truncated variants), the enzymes' hydrolytic ability on various polymeric substrates was significantly restored: the relative activities of both remained at 92% and 70% for colloidal chitin, 65% and 49% for α-chitin, and 88% and 64% for β-chitin, respectively.

[0050] Example 5: Enzymatic kinetics study of the truncated form of chitinase VpCHI-1 Under optimal conditions, the kinetic parameters of the VpCHI-1 truncated body were determined using colloidal chitin as a substrate.

[0051] Chitinase activity was measured by incubating 50 μg / ml of purified VpCHI-1 in 20 mmol / L Tris-HCl buffer containing 0 to 15 mg / mL colloidal chitin at 35 °C and 180 rpm for 30 minutes.

[0052] The kinetic values ​​obtained from three parallel experiments were fitted to the Michaelis-Menten equation using the nonlinear regression function of Origin Graph 2021 software, as shown in Figure 9. Figure 10 As shown.

[0053] Experiments show that ChtBD3 plays a crucial role in substrate recognition and binding. Further deletion of the PKD domain led to a continuous increase in the enzyme's Km value and a sharp decrease in catalytic efficiency (Kcat / Km). The truncated form containing only the GH18 catalytic domain exhibited catalytic efficiency reduced to 12% of the full-length enzyme.

[0054] Example 6: Enzymatic hydrolysis effect of VpCHI-1 on crude chitin resources The changes in the surface structure of crab shells after treatment with VpCHI-1 and its truncated mutants were observed using scanning electron microscopy. The treatment solution concentration was set to 50 μg / mL, and after reacting at a constant temperature for 24 hours, the treated samples were dehydrated, dried, and sputter-coated with gold using standard methods. The microstructure was then observed using a JSM-6390 / LV scanning electron microscope at an accelerating voltage of 10.0 kV. Figure 11 As shown.

[0055] By comparing the microscopic morphological differences between natural crab shells and treated samples, the degradation characteristics and action mode of the enzyme and its truncated form on chitin structure were analyzed.

[0056] The embodiments described above are merely preferred embodiments of the present invention, and not all feasible embodiments of the present invention. Any obvious modifications made by those skilled in the art without departing from the principles and spirit of the present invention should be considered to be included within the scope of protection of the claims of the present invention.

Claims

1. A chitinase VpCHI-1 domain truncated mutant, characterized in that, The amino acid sequence is one of SEQ ID NO.2, SEQ ID NO.3, or SEQ ID NO.

4.

2. The coding gene of a chitinase VpCHI-1 domain truncated mutant, characterized in that, The nucleotide sequence of the encoding gene is shown in SEQ ID NO.5, SEQ ID NO.6 and SEQ ID NO.

7.

3. A carrier, characterized in that, The vector contains the encoding gene as described in claim 2.

4. The carrier according to claim 3, characterized in that, The vectors include plasmids, viruses, and bacteriophages.

5. A host cell, characterized in that, The host cell contains the encoding gene as described in claim 2 or the vector as described in claim 3.

6. The host cell according to claim 5, characterized in that, The host cell includes microbial, plant, or animal cells.

7. The use of the encoding gene as described in claim 2, the vector as described in claim 3, or the host cell as described in claim 52 in the preparation of chitinase mutants.

8. The method for preparing the chitinase VpCHI-1 domain truncated mutant as described in claim 1, characterized in that step... include: S1. The above nucleic acid molecules are ligated to a plasmid vector to obtain a recombinant plasmid; S2. The recombinant plasmid is transformed into the cloning strain to obtain the recombinant cloning strain; S3. Extract the plasmid from the recombinant cloning strain and transform it into the expression strain to obtain the recombinant expression strain; S4. The recombinant expression strain was induced and cultured, the bacterial cells were collected and broken to obtain chitinase; Induction culture process: The recombinant engineered bacteria were inoculated into 10 mL LB liquid medium containing 50 μg / mL kanamycin and activated by incubation at 37℃ and 180 r / min for 12-16 h to obtain seed culture. 1 mL of seed culture was transferred to 100 mL of fresh medium and amplified under the same conditions for 5 h. IPTG was then added to achieve a final concentration of 0.15 mmol / L, and the culture was incubated overnight at 15℃ and 100 r / min.

9. The application of the chitinase VpCHI-1 domain truncated mutant as described in claim 1 in the degradation of natural crystalline chitin to prepare chitin oligosaccharides.